Summary

The Asia-Pacific wound care monitoring market is expected to reach USD 1.87 billion by 2031 from USD 1.61 billion in 2023, growing at a CAGR of 6.2% in the forecast period of 2024 to 2031.
Market Segmentation:
Asia-Pacific Wound Care Monitoring Market, By Product (Devices and Wound Assessment Apps), Modality (Wearable and Non-Wearable), Product Type (Contact Wound Measuring Devices and Non-Contact Wound Measuring Devices), Wound Type (Chronic Wounds and Acute Wounds), Application (Wound Healing Monitoring, Wound Assessment, Infection Detection, and Treatment Monitoring), End User (Hospitals, Clinics, Home Healthcare, Long-Term Care Facilities, Trauma Centers, and Others), Distribution Channel (Direct Tenders and Retail Sales), Country (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Singapore, Philippines, and rest of Asia-Pacific) - Industry Trends and Forecast to 2031

Overview of Asia-Pacific Wound Care Monitoring Market Dynamics:
Driver
• Increasing prevalence of chronic diseases
Restraint
• High costs of advanced devices
Opportunity
• Increasing technological advancement in wound care

Market Players:
The key market players operating in the Asia-Pacific wound care monitoring market are listed below:
• Smith+Nephew
• Medline Industries, LP
• Mölnlycke Health Care AB
• Convatec Group PLC
• 3M
• The MolecuLight
• eKARE, Inc.
• Advanced Oxygen Therapy Inc.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 44
1.1 OBJECTIVES OF THE STUDY 44
1.2 MARKET DEFINITION 44
1.3 OVERVIEW OF THE ASIA-PACIFIC WOUND CARE MONITORING MARKET 44
1.4 CURRENCY AND PRICING 46
1.5 LIMITATIONS 46
1.6 MARKETS COVERED 46
2 MARKET SEGMENTATION 49
2.1 MARKETS COVERED 49
2.2 GEOGRAPHICAL SCOPE 50
2.3 YEARS CONSIDERED FOR THE STUDY 51
2.4 DBMR TRIPOD DATA VALIDATION MODEL 52
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 55
2.6 MULTIVARIATE MODELLING 56
2.7 MARKET END USER COVERAGE GRID 57
2.8 PRODUCT LIFELINE CURVE 58
2.9 DBMR MARKET POSITION GRID 59
2.10 VENDOR SHARE ANALYSIS 60
2.11 SECONDARY SOURCES 61
2.12 ASSUMPTIONS 61
3 EXECUTIVE SUMMARY 62
4 PREMIUM INSIGHTS 67
4.1 PESTAL ANALYSIS 68
4.2 PORTERS FIVE FORCES 69
5 REGULATION COVERAGE 70
6 MARKET OVERVIEW 72
6.1 DRIVERS 74
6.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 74
6.1.2 INCREASING THE NUMBER OF PRODUCT LAUNCHES 76
6.1.3 STRATEGIC INITIATION AND DECISION TAKEN BY THE MARKET PLAYERS 77
6.1.4 INCREASING GOVERNMENTAL SUPPORT AND THE R&D EXPENDITURE 78
6.2 RESTRAINTS 80
6.2.1 HIGH COSTS OF ADVANCED DEVICES 80
6.2.2 TECHNICAL CHALLENGES AND ACCURACY CONCERNS 80
6.2.3 CONSOLIDATION AMONG PAYERS AND BUYERS 81
6.3 OPPORTUNITIES 83
6.3.1 INCREASING TECHNOLOGICAL ADVANCEMENT IN WOUND CARE 83
6.3.2 INCREASING NUMBER OF PATIENTS UNDERGOING SURGICAL PROCEDURES 84
6.3.3 DIGITAL HEALTH INTERVENTIONS FOR CHRONIC WOUND MANAGEMENT 85
6.4 CHALLENGES 86
6.4.1 LACK OF SKILLED LABOR FORCE 86
6.4.2 COMPLEXITY INVOLVED IN THE USAGE OF THE DEVICES 86
7 ASIA-PACIFIC WOUND CARE MONITORING MARKET, BY PRODUCT 88
7.1 OVERVIEW 89
7.2 DEVICES 92
7.2.1 WOUND MEASUREMENT DEVICES 93
7.2.2 WOUND DRESSINGS WITH INTEGRATED SENSORS 93
7.2.3 SMART BANDAGES 93
7.2.4 WOUND INFECTION DETECTION SENSORS 93
7.2.5 PH MONITORING DEVICES 93
7.2.6 WOUND IMAGING SYSTEMS 93
7.2.6.1 DIGITAL IMAGING 93
7.2.6.2 FLUORESCENCE IMAGING 93
7.2.6.3 INFRARED THERMOGRAPHY 93
7.2.6.4 OPTICAL COHERENCE TOMOGRAPHY (OCT) 93
7.2.6.5 OTHERS 93
7.2.7 MOISTURE MANAGEMENT SYSTEMS 93
7.2.8 PRESSURE ULCER MONITORING DEVICES 93
7.2.9 DIGITAL WOUND DOCUMENTATION SYSTEMS 93
7.2.10 OTHERS 93
7.3 WOUND ASSESSMENT APPS 94
8 ASIA-PACIFIC WOUND CARE MONITORING MARKET, BY PRODUCT TYPE 95
8.1 OVERVIEW 96
8.2 CONTACT WOUND MEASURING DEVICES 99
8.3 NON-CONTACT WOUND MEASURING DEVICES 99
9 ASIA-PACIFIC WOUND CARE MONITORING MARKET, BY MODALITY 100
9.1 OVERVIEW 101
9.2 WEARABLE 104
9.3 NON-WEARABLE 104
9.3.1 STANDALONE 105
9.3.2 PORTABLE 105
10 ASIA-PACIFIC WOUND CARE MONITORING MARKET, BY WOUND TYPE 106
10.1 OVERVIEW 107
10.2 CHRONIC WOUNDS 110
10.2.1 DIABETIC FOOT ULCERS 110
10.2.2 PRESSURE ULCERS 110
10.2.3 VENOUS LEG ULCERS 110
10.2.4 ARTERIAL ULCERS 110
10.3 ACUTE WOUNDS 111
10.3.1 SURGICAL WOUNDS 111
10.3.2 TRAUMATIC WOUNDS 111
10.3.3 BURN WOUNDS 111
11 ASIA-PACIFIC WOUND CARE MONITORING MARKET, BY APPLICATION 112
11.1 OVERVIEW 113
11.2 WOUND HEALING MONITORING 116
11.3 WOUND ASSESSMENT 116
11.3.1 SIZE MEASUREMENT 117
11.3.2 DEPTH MEASUREMENT 117
11.3.3 TISSUE TYPE ASSESSMENT 117
11.4 INFECTION DETECTION 117
11.5 TREATMENT MONITORING 118
12 ASIA-PACIFIC WOUND CARE MONITORING MARKET, BY DISTRIBUTION CHANNEL 119
12.1 OVERVIEW 120
12.2 DIRECT TENDERS 123
12.3 RETAIL SALES 123
12.3.1 OFFLINE 124
12.3.2 ONLINE 124
13 ASIA-PACIFIC WOUND CARE MONITORING MARKET, BY END USER 125
13.1 OVERVIEW 126
13.2 HOSPITALS 129
13.2.1 INPATIENT 129
13.2.2 OUTPATIENT 129
13.3 CLINICS 130
13.3.1 WOUND CARE CLINICS 130
13.3.2 DERMATOLOGY CLINICS 130
13.4 HOME HEALTHCARE 131
13.5 LONG-TERM CARE FACILITIES 131
13.6 TRAUMA CENTERS 132
13.7 OTHERS 132
14 ASIA-PACIFIC WOUND CARE MONITORING MARKET, BY REGION 133
14.1 ASIA-PACIFIC 135
14.1.1 CHINA 141
14.1.2 JAPAN 146
14.1.3 INDIA 151
14.1.4 SOUTH KOREA 156
14.1.5 AUSTRALIA 161
14.1.6 THAILAND 166
14.1.7 MALAYSIA 171
14.1.8 INDONESIA 176
14.1.9 SINGAPORE 181
14.1.10 PHILIPPINES 186
14.1.11 REST OF ASIA-PACIFIC 191
15 ASIA-PACIFIC WOUND CARE MONITORING MARKET: COMPANY LANDSCAPE 192
15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS 193
17 COMPANY PROFILE 194
17.1 SMITH+NEPHEW 194
17.1.1 COMPANY SNAPSHOT 194
17.1.2 REVENUE ANALYSIS 194
17.1.3 COMPANY SHARE ANALYSIS 195
17.1.4 PRODUCT PORTFOLIO 195
17.1.5 RECENT DEVELOPMENT 196
17.2 MEDLINE INDUSTRIES, LP 197
17.2.1 COMPANY SNAPSHOT 197
17.2.2 COMPANY SHARE ANALYSIS 197
17.2.3 PRODUCT PORTFOLIO 198
17.2.4 RECENT DEVELOPMENTS 198
17.3 MÖLNLYCKE HEALTH CARE AB 200
17.3.1 COMPANY SNAPSHOT 200
17.3.2 COMPANY SHARE ANALYSIS 200
17.3.3 PRODUCT PORTFOLIO 201
17.3.4 RECENT DEVELOPMENT 201
17.4 CONVATEC GROUP PLC 202
17.4.1 COMPANY SNAPSHOT 202
17.4.2 REVENUE ANALYSIS 202
17.4.3 COMPANY SHARE ANALYSIS 203
17.4.4 PRODUCT PORTFOLIO 203
17.4.5 RECENT DEVELOPMENTS 203
17.5 3M 205
17.5.1 COMPANY SNAPSHOT 205
17.5.2 REVENUE ANALYSIS 205
17.5.3 PRODUCT PORTFOLIO 206
17.5.4 RECENT DEVELOPMENT 207
17.6 ADVANCED OXYGEN THERAPY INC. 208
17.6.1 COMPANY SNAPSHOT 208
17.6.2 1.1.4 REVENUE ANALYSIS 208
17.6.3 SOLUTION PORTFOLIO 209
17.6.4 RECENT DEVELOPMENT 209
17.7 DIGITALMEDLAB LTD. 210
17.7.1 COMPANY SNAPSHOT 210
17.7.2 PRODUCT PORTFOLIO 210
17.7.3 RECENT DEVELOPMENT 210
17.8 EKARE, INC. 211
17.8.1 COMPANY SNAPSHOT 211
17.8.2 PRODUCT PORTFOLIO 211
17.8.3 RECENT DEVELOPMENT 211
17.9 IMITO AG 212
17.9.1 COMPANY SNAPSHOT 212
17.9.2 PRODUCT PORTFOLIO 212
17.9.3 RECENT DEVELOPMENT 212
17.10 SPECTRAL AI, INC. 213
17.10.1 COMPANY SNAPSHOT 213
17.10.2 REVENUE ANALYSIS 213
17.10.3 PRODUCT PORTFOLIO 214
17.10.4 RECENT DEVELOPMENT 214
17.11 SWIFT MEDICAL INC. 215
17.11.1 COMPANY SNAPSHOT 215
17.11.2 SOLUTION PORTFOLIO 215
17.11.3 RECENT DEVELOPMENT 215
17.12 THE MOLECULIGHT 216
17.12.1 COMPANY SNAPSHOT 216
17.12.2 SOLUTION PORTFOLIO 216
17.12.3 RECENT DEVELOPMENT 217
17.13 TISSUE ANALYTICS 218
17.13.1 COMPANY SNAPSHOT 218
17.13.2 PRODUCT PORTFOLIO 218
17.13.3 RECENT DEVELOPMENT 218
17.14 THERMOTEK 219
17.14.1 COMPANY SNAPSHOT 219
17.14.2 PRODUCT PORTFOLIO 219
17.14.3 RECENT DEVELOPMENT 219
17.15 WOUNDMATRIX MOBILE WOUND MANAGEMENT 220
17.15.1 COMPANY SNAPSHOT 220
17.15.2 SERVICE PORTFOLIO 220
17.15.3 RECENT DEVELOPMENT 220
17.16 WOUNDVISION 221
17.16.1 COMPANY SNAPSHOT 221
17.16.2 SOLUTION PORTFOLIO 221
17.16.3 RECENT DEVELOPMENT 221
18 QUESTIONNAIRE 222
19 RELATED REPORTS 225